Genomic investigation of α-synuclein multiplication and parkinsonism

Annals of Neurology

Volumn 63, Issue 6, 2008, Pages 743-750

  Ross, Owen A ^a   Braithwaite, Adam T ^a   Skipper, Lisa M ^a   Kachergus, Jennifer ^a   Hulihan, Mary M ^a   Middleton, Frank A ^b   Nishioka, Kenya ^c   Fuchs, Julia ^d   Gasser, Thomas ^d   Maraganore, Demetrius M ^e   Adler, Charles H ^f   Larvor, Lydie ^g   Chartier Harlin, Marie Christine ^g   Nilsson, Christer ^h   Langston, J William ⁱ   Gwinn, Katrina ^j   Hattori, Nobutaka ^c   Farrer, Matthew J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e Mayo Clinic   (United States)

^f MAYO CLINIC   (United States)

^g Institut de Recherche sur le Cancer de Lille   (France)

^h LUND UNIVERSITY   (Sweden)

ⁱ PARKINSON S INSTITUTE   (United States)

^j NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; MICROSATELLITE DNA;

ADULT; AGED; ALLELE; ARTICLE; AUTONOMIC DYSFUNCTION; CENTROMERE; CHROMOSOME 4Q; CHROMOSOME DUPLICATION; COPY NUMBER VARIATION; DEMENTIA; DISEASE SEVERITY; DNA MICROARRAY; GENE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MICROSATELLITE MARKER; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PARKINSONISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SNCA GENE; TELOMERE;

EID: 46749144187     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21380     Document Type: Article

References (43)

1. Simon-Sanchez J, Scholz S, Fung HC, et al. Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals. Hum Mol Genet 2007;16:1-14.
2. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006;444:444-454.
3. Wong KK, Deleeuw RJ, Dosanjh NS, et al. A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet 2007;80:91-104.
4. Singleton AB, Farrer M, Johnson J, et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003;302:841.
5. Chartier-Harlin MC, Kachergus J, Roumier C, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004;364:1167-1169.
6. Farrer M, Kachergus J, Forno L, et al. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 2004;55:174-179.
7. Ibanez P, Bonnet AM, Debarges B, et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 2004;364:1169-1171.
8. Lockhart PJ, Kachergus J, Lincoln S, et al. Multiplication of the alpha-synuclein gene is not a common disease mechanism in Lewy body disease. J Mol Neurosci 2004;24:337-342.
9. Nishioka K, Hayashi S, Farrer MJ, et al. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease. Ann Neurol 2006;59:298-309.
10. Johnson J, Hague SM, Hanson M, et al. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology 2004;63:554-556.
11. Fuchs J, Nilsson C, Kachergus J, et al. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 2007;68:916-922.
12. Muenter MD, Forno LS, Hornykiewicz O, et al. Hereditary form of parkinsonism - dementia. Ann Neurol 1998;43:768-781.
13. Gajovic S, Mitrecic D, Augustincic L, et al. Unexpected rescue of alpha-synuclein and multimerin1 deletion in C57BL/6JOlaHsd mice by beta-adducin knockout. Transgenic Res 2006;15:255-259.
14. Specht CG, Schoepfer R. Deletion of multimerin-1 in alpha-synuclein- deficient mice. Genomics 2004;83:1176-1178.
15. Hope AD, Myhre R, Kachergus J, et al. Alpha-synuclein missense and multiplication mutations in autosomal dominant Parkinson's disease. Neurosci Lett 2004;367:97-100.
16. Ahn TB, Kim SY, Kim JY, et al. {alpha}-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology 2008;70:43-49.
17. Spira PJ, Sharpe DM, Halliday G, et al. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. Ann Neurol 2001;49:313-319.
18. Obi T, Nishioka K, Ross OA, et al. Clinicopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia. Neurology 2008;70:238-241.
19. Janne PA, Li C, Zhao X, et al. High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines. Oncogene 2004;23:2716-2726.
20. Lieberfarb ME, Lin M, Lechpammer M, et al. Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP. Cancer Res 2003;63:4781-4785.
21. Lin M, Wei LJ, Sellers WR, et al. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 2004;20:1233-1240.
22. Frazer KA, Pachter L, Poliakov A, et al. VISTA: computational tools for comparative genomics. Nucleic Acids Res 2004;32:W273-W279.
23. Batzer MA, Deininger PL. Alu repeats and human genomic diversity. Nat Rev Genet 2002;3:370-379.
24. Price AL, Eskin E, Pevzner PA. Whole-genome analysis of Alu repeat elements reveals complex evolutionary history. Genome Res 2004;14:2245-2252.
25. Bailey JA, Liu G, Eichler EE. An Alu transposition model for the origin and expansion of human segmental duplications. Am J Hum Genet 2003;73:823-834.
26. Farrer MJ. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 2006;7:306-318.
27. Hayward CP, Rivard GE, Kane WH, et al. An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood 1996;87:4967-4978.
28. Liu H, Liu W, Wu Y, et al. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res 2005;65:7635-7643.
29. Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 2006;12:192-198.
30. Gosal D, Ross OA, Toft M. Parkinson's disease: the genetics of a heterogeneous disorder. Eur J Neurol 2006;13:616-627.
31. Mjönes H. Paralysis agitans: clinical and genetic study. Acta Psychiatr Neurol Scand Suppl 1949;54:1-195.
32. Manto MU. The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum 2005;4:2-6.
33. Rovelet-Lecrux A, Hannequin D, Raux G, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 2006;38:24-26.
34. Chiba-Falek O, Nussbaum RL. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum Mol Genet 2001;10:3101-3109.
35. Kruger R, Vieira-Saecker AM, Kuhn W, et al. Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/ apolipoprotein E genotype. Ann Neurol 1999;45:611-617.
36. Tan EK, Tan C, Shen H, et al. Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability. Neurosci Lett 2003;336:70-72.
37. Farrer M, Maraganore DM, Lockhart P, et al. alpha-Synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet 2001;10:1847-1851.
38. Maraganore DM, de Andrade M, Elbaz A, et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. Jama 2006;296:661-670.
39. Fung HC, Scholz S, Matarin M, et al. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 2006;5:911-916.
40. Maraganore DM, de Andrade M, Lesnick TG, et al. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 2005;77:685-693.
41. Simon-Sanchez J, Scholz S, Del Mar Matarin M, et al. Genomewide SNP assay reveals mutations underlying Parkinson disease. Hum Mutat 2008;29:315-322.
42. Dachsel JC, Lincoln SJ, Gonzalez J, et al. The ups and downs of alpha-synuclein mRNA expression. Mov Disord 2007;22:293-295.
43. Zhang Y, James M, Middleton FA, Davis RL. Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet 2005;137:5-16.